Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Why The Coming Silver Rally Might Be The Greatest

In the last one hundred years there have been some great silver rallies. Some have been greater than others though. The economic conditions underlying the different silver rallies were not all the same. Obviously those that occurred during conditions most conducive to silv...
Hubert Moolman | July 23, 2019 |

Why XOM is close to an ideal option trading candidate

XOM has a hugely active options series, trades in both monthly and weekly expiration series and has bid / ask spreads that are just a few pennies wide. One of the most interesting aspects of options is the myriad opportunities presented for high probability trades for thos...
J.W. Jones | February 6, 2013 |

Analyst: Biopharma, Now Stronger Than Ever, Is an Ideal Takeout Target

An argument is made in a ROTH Capital Partners report for a potential imminent deal involving this drug maker. In an April 15 research note, ROTH Capital Partners analyst Yasmeen Rahimi reviewed the reasons why Galmed Pharmaceuticals Ltd. (GLMD:NASDAQ) is "high on the...
Streetwise Reports | April 18, 2019 |

Precious Metals Reentry Time: Not Ideal but Enough for a Trade

I was looking over the charts last night (over a fine Merlot and some fava beans), trying desperately to avoid the temptation of attending that embarrassment of capitalism called PDAC. The mining conference held annually in Toronto has transformed from an industrial showc...
Streetwise Reports | March 11, 2019 |

This Unique App “Matches the Perfect Customer to the Ideal Vehicle”

Negotiating a new vehicle purchase is often an exercise in futility and sometimes ends in frustration. Now, there’s a Canadian company that’s offering a unique new app that makes the entire purchase and financing easy. How? By bringing the ve...
Dave Jackson | May 2, 2022 |

Silver Could Be Close To An Important Resolution

Silver is still in consolidation mode since early September, but could be close to a resolution. Below, is chart of silver: On the chart there appears to have formed some fractals. The current one has also broken out at the blue line in middle to late December of ...
Hubert Moolman | January 23, 2020 |

Common Stock Warrants Are a Powerful Wealth Building Tool with Dudley Baker

I recently did this interview with Kerry Lutz and we walk through investment possibilities with mining shares and stock warrants. There is a short advertising break in the middle, so don't leave the interview until completed. Common Stock Warrants Are a Powerful ...
Dudley Pierce Baker | January 30, 2020 |

Silver and the Yield Curve Inversion

Yield curve inversions have historically been great for silver prices. Currently we are experiencing such a phenomena, and again it is evidence of conditions that are conducive to some impressive silver rallies. Below, is a long-term chart showing the spread between the 10...
Hubert Moolman | September 23, 2019 |

When Will GDX Break-out?

If you follow our work, you are aware of our growing optimism on gold stocks in 2020. As we've written, the fundamental setup in 2020 should be bullish for precious metals. Meanwhile, the technical setup for gold stocks is one of the best we’ve ever see...
Jordan Roy-Byrne, CMT | December 12, 2019 |

XPhyto to Announce PCR Test Kit Final Validation Results

It could be the Holy Grail of COVID-19 testing. Remarkably, a small Canadian life sciences company, XPhyto Therapeutics Corp. (CSE: XPHY) (FSE: 4XT) is becoming a front-runner in the race to bring this breakthrough technology to market – starting with Germany. This ref...
Marc Davis | November 26, 2020 |
1 2 3 4 5 6 7 8 9 10 ...